5
Views
2
CrossRef citations to date
0
Altmetric
CNS Agents

Patent Update: Cerebral Anti-lschaemic Agents: Recent Advances, June Through December, 1991

Pages 146-162 | Published online: 02 Mar 2011

References to Primary References

  • Source Drug and Market Development March 23, 19919–15.
  • Sosin DM, Sacks JJ, Smith SM J Am. Med. Assn. 1989 262 2251.
  • A recent summary of current mechanistic targets for anti-ischaemic therapy can be found in Pharmacology of Cerebral Ischemia Krieglstein J Oberpichler H Wiss. Ver. mbHStuttgart 1990.
  • Numerous patents included ‘anti-ischaemic’ among potential uses. This review concentrates on patents which either presented data demonstrating potential anticerebral ischaemic activity or disclosed new, relatively unexplored potential mechanisms for neuroprotection.
  • Scantton B, Frost J, George P, Carter C, Benavides J Current Opin. Thera. Patents 1991 1 523.
  • Choi DW Ann. Rev. Neurosci. 1990 13 171.
  • Johnson G, Bigge CF Ann. Reports Med. Chem. 199126 11; Fidia Foundation Symposium Series, vol 5; Excitatory Amino Acids Meldrum BS Moroni F Simon RP Woods JH Raven PressNew York 1991.
  • Pellegrini J, Chen H-SV, Lei SZ, Sucher NJ, Lipton SA21st Annual Meeting of the Society for Neuroscience, Nov. 10–15, 1991 New Orleans, LAA6.8.
  • Reynolds IJ, Aizenman E21st Annual Meeting of the Society for Neuroscience, Nov. 10–15, 1991 New Orleans, LAA6.9.
  • Hollmann M, Hartley M, Heineman S Science 1991 252 851.
  • Ly AM, Michaelis EK Biochemistry 1991 30 4307.
  • Moriyoshi M, Masu M, Ishii T, Shigemoto R, Mizuno N, Nakanishi S Nature 1991 354 31.
  • Ray R, Julien R, Gordon J, Blosser J21 st Annual Meeting of the Society for Neuroscience, Nov. 10–15, 1991 New Orleans, LAA163.3.
  • Wenganack TM, Ordy JM, Bialobok P21st Annual Meeting of the Society for Neuroscience, Nov. 10–15, 1991 New Orleans, LAA194.21.
  • Ordy JM, Thomas GJ, Bialobok P, Wenganack TM, Murray RJ, Dunlap WP21st Annual Meeting of the Society for Neuroscience, Nov. 10–15, 1991 New Orleans, LA A426.3.
  • Priestley T, Wooduff GN, Kemp JA Br. J. Pharmacol. 1989 97 1315.
  • Gill R, Lodge DXVth International Symposium on Cerebral Blood Flow, June 1–6, 1991 Miami, Fl.
  • Garthwaite J Trends in Neurosci. 1991 14 60 For a recent review, see.
  • McGeer EG, Shu SG Neurosci. Lett. 1990 112 348.
  • Nobbs MS6th SCI-RSC Medicinal Chemistry Symposium, Sept. 8–11, 1991 Churchill CollegeCambridge, UK.
  • Pontecorvo MJ, Karbon EW, Goode S, Clissold DB, Borosky SA, Patch RJ, Ferkany JW Brain Res. Bull. 1991 26 461.
  • Norvicki JP, Gibald K, Alize F, Scatton B J. Cereb. Blood Flow and Metab. 1991 11 suppl 2 S311.
  • Lambert PD, Woodruff GN, Hughes J, Hunter JC Mol. Neuropharmacol. 1991 1 77.
  • Vanhoutte PM J. Cardiovascular Pharmacol. 1990 16 suppl 3 S15 For recent reviews, see.
  • Joseph R, Tsering C, Grunfeld S, Welch KMA Stroke 1991 20 1448.
  • Prehn JHM, Backhauss C, Karhoutley C, Nuglisch J, Peruche B, Rossberg C, Krieglstein J Eur. J. Pharmacol. 1991 203 213 For recent publications see.
  • Ohno M, Yamamoto T, Watanabe S Neurosci. Lett. 1991 129 185.
  • Globus MY-T, Busto R, Dietrich WD, Martinez E, Valdes I, Ginsberg M J. Cereb. Blood Flow and Metab. 1989 9 892.
  • Hoffman WE, Cheng MA, Thomas C, Baughman VL, Albrecht RF Anesth. Analg. 1991 73 460.
  • Globus MY-T, Ginsberg M, Busto R Neurosci. Lett. 1991 127 39.
  • Johansen FF, Christensen T, Jensen CV, Nathan T, Lambert JDC, Diemer NH Exp. Brain Res. 1991 84 529.
  • Kumagae Y, Matsui Y J. Neurochem. 1991 56 1169.
  • Scremen OU, Jenden DJ Stroke 1989 20 92.
  • Scremin OU, Jenden DJ Stroke 1989 20 1524.
  • Scremin OU Ann. Rev. Pharmacol. Toxicol. 1991 31 229 For a review see.
  • Phillis JW, Walter GA, Simpson RE J. Neurochem. 1991 56 644 and references therin.
  • Saccomano NA, Ganong AH Ann. Reports Med. Chem. 1991 26 33.
  • Jacobsen EJ, McCall JM Ann. Reports Med. Chem. 1990 25 31 and references therin.
  • Hall ED, Braughler JM, Yonkers PA, Smith SL, Linseman KL, Means ED, Scherch HM, Von Voightlander PF, Lahti RA, Jacobsen EJ J. Pharmacol. Exp. Ther. 1991 258 688.
  • Schinstine M, Gage F Ann. Reports Med. Chem. 1990 25 245 For recent reviews, see.
  • Urdal DL Ann. Reports Med. Chem. 1991 26 221.
  • Shinego T, Mima T, Takakura K, Katoh G, Hashimoto Y, Furukawa S, Graham DI Adv. Behav. Biol. 1990 38B 467.
  • Von Harrer G, Melnizky U, Wagner F Arzneim-Forsch. 1972 22 900.
  • Trojanova M, Karasek F, Prozkova V, Mourek M Physiol. Bohemoslov. 1976 25 319.
  • Anderson J Trends Neurosci. 1989 52 83.
  • Mazzari S, Lipartiti SS, Fadda E, Koga T, Lazarro A, Leon A, Toffano G Pharmacology of Cerebral Ischemia Krieglstein J Oberpichler H Wiss Ver. mbHStuttgart 1990541–551 For a recent review on GM1 action see.
  • Faden AI, Yum SW, Lemke M, Vink R J. Pharmacol. Exp. Ther. 1990 255 608.
  • Takayuki O, Satoru S, Hiroshi S, Masashi THighlights Ubiquinone Res. Proc. Int. Symp. Biochem. Bioenerg. Clin. Appl. Ubiquinone 19891990214.
  • Xu C, Xue D, Su MC, Du LF, Gu X, Yang CL, Liu F Peptides 1987 8 769.
  • Kochanek PM, Nemoto EM, Evans RW, Schoettle RJ New Trends in Lipid Mediators Research Braquet P Karger 1990 4 220–240.
  • Clark WM, Madden KP, Rothlein R, Zivin JA Stroke 1991 22 877.
  • Clark WM, Madden KP, Rothlein R, Zivin JA J. Neurosurg. 1991 75 623.
  • Jiyun L Drugs of the Future 1991 16 904.

References to Patent Literature

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.